Hematopoietic progenitor cell gene transduction
US8318495B1 · kind B1 · utility
0Cited by
4References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 28, 1999 |
| Grant date | Nov 27, 2012 |
| Priority date | — |
| Expiry date | Jul 5, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Genetically engineered hematopoietic progenitor cells that carry within them genes of interest, particularly for the expression of physiologically or pharmacologically active proteins. The hematopoietic progenitor cells are transduced in the presence of human mesenchymal stem cells which enhance transduction efficiency.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.